SparingVision
PrivateLast Round
Series B
Sep 14, 2022
Total Funding Raised
$130.49M
Company Overview
SparingVision is a biotechnology company developing genomic medicines and gene-agnostic therapies for inherited retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SparingVision Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
SparingVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 14, 2022 | ||||
| Series A | Oct 21, 2020 | ||||
| Grant | Jul 9, 2019 | ||||
| Grant | Jul 12, 2017 |
Key People
Founding team and executive leadership
SparingVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Programme d'Investissements d'Avenir | Series B |
| European Innovation Council Fund | Grant |
| Ministry of Higher Education and Research | Grant |
| Ysios Capital | Series A, Series B |
| Bpifrance | Series A, Grant, Series B |
| 4BIO Capital | Series B, Series A |
| Sofimac Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2025
Kalliopi 'Kali' Stasi appointed as the new Chief Medical Officer.
- May 19, 2025
Presented PRODYGY data and research update at ASGCT 2025.
SparingVision Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SparingVision's valuation, stock price, and market status.